Equifax Inc. (EFX), headquartered in Atlanta, Georgia, is a prominent global data, analytics, and technology company delivering credit reporting, identity verification, fraud prevention, and related services to businesses, governments, and consumers. Its market capitalization stands at around $31.7 billion. Among its innovations is the recent launch of Identity Proofing in its Kount 360 platform, aimed at strengthening onboarding and fraud detection workflows.

Companies with a market cap of $10 billion or more are typically classified as “large-cap,” a category that signals established firms with strong financial muscle and global reach. Equifax fits firmly within this class, underscoring its stability, scale, and competitive edge. Its diversified offerings, along with its recent achievements, reinforce its market leadership and growth potential.

EFX stock is around 17% below its 52-week high of $307.08, reached on Sept. 19, 2024. Shares of Equifax have declined 4.1% over the past three months, underperforming the broader Industrial Select Sector SPDR Fund’s (XLI) 6% rise over the same time frame.

In the longer term, EFX stock has gained marginally on a year-to-date (YTD) basis but declined 15.7% over the past 52 weeks, again underperforming compared to XLI’s gains of 15.5% YTD and 16% over the past year.

While the stock has been trading below the 50-day and 200-day moving averages since late July, it has been gaining some traction lately, trading above the moving averages recently. 

Over the past year, Equifax’s shares have underperformed, partly due to macroeconomic headwinds and segment-specific challenges. A major drag has been the weak mortgage market, as high interest rates and elevated home prices have reduced mortgage origination and credit inquiries, one of Equifax’s revenue drivers. Also, a weaker hiring market and regulatory issues affected investor sentiments. 

Compared to one of its peers, Verisk Analytics, Inc. (VRSK), EFX has outperformed on a YTD basis as VRSK declined 7.4% over the period. However, VRSK declined 5.1% over the past year, compared to the 16.3% plunge of EFX. 

Wall Street analysts are moderately bullish on EFX’s prospects. The stock has a consensus “Moderate Buy” rating from the 24 analysts covering it, and the mean price target of $280.24 suggests a potential upside of 9.1% from current price levels.